Huihua Xiong

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-7752-5724

发表论文 112 篇 · 总被引 2577 次 · h-index 25

代表论文

• Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 122)
• Self‐Cascade Nanozyme Reactor as a Cuproptosis Inducer Synergistic Inhibition of Cellular Respiration Boosting Radioimmunotherapy (2024 · Small · 被引 61)
• The History and Development of HER2 Inhibitors (2023 · Pharmaceuticals · 被引 29)
• Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial (2023 · BMC Medicine · 被引 17)
• Hetrombopag plus recombinant human thrombopoietin for chemotherapy-induced thrombocytopenia in patients with solid tumors (2023 · Research and Practice in Thrombosis and Haemostasis · 被引 10)
• Novel 4-Amino-Quinazoline moieties ligated Platinum(IV) prodrugs overcome cisplatin resistance in EGFRWT human lung cancer (2023 · Bioorganic Chemistry · 被引 10)